ArticleAmerican journal of translational research2025
Antibacterial activity of local anesthetics against multidrug-resistant bacteria in vitro.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesLocal anesthetics are widely used in clinical settings for pain management. In addition to their analgesic effects, they may also exhibit antimicrobial properties. However, data on their activity against multidrug-resistant (MDR) pathogens are limited. This study aimed to evaluate the in vitro antibacterial activity of lidocaine, levobupivacaine, and bupivacaine against MDR bacteria, including Pseudomonas aeruginosa (MRPA), carbapenem-resistant Enterobacterales (CRE), and Acinetobacter baumannii (MRAB).
methodsThe minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of each anesthetic were determined using the standardized broth microdilution method according to CLSI guidelines. Clinical isolates of MRPA, CRE, and MRAB were tested. Identification was performed using MALDI-TOF MS and VITEK II systems. The local anesthetics were diluted to clinically relevant concentrations and tested in duplicate.
resultsBupivacaine exhibited the strongest antimicrobial activity, with MICs of 1.6 mg/mL for MRAB and 3.2 mg/mL for CRE. Lidocaine showed limited activity, with an MIC of 16 mg/mL for MRPA. Levobupivacaine showed intermediate effects. In all cases, MBCs were higher than the corresponding MICs. These findings suggest differential antibacterial efficacy among the agents.
conclusionsLocal anesthetics demonstrated measurable antibacterial effects against MDR pathogens in vitro. Bupivacaine showed the strongest activity but has a lower clinical dosage limit due to its cardiotoxicity. While lidocaine has weaker antibacterial potency, its widespread use and safety profile make it a practical option. These results suggest local anesthetics may play a complementary role in infection-prone procedures but require cautious interpretation for clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.